transplant rejection
CareDx Receives CE Mark for Hematopoietic Cell Transplantation Testing Kit, Analysis Software
The designation furthers the firm's expansion into the stem cell transplant space, which began with the launch of AlloCell in 2020.
CareDx Q1 Revenues up 18 Percent
The firm said March was its highest ever month of testing volume for its heart and kidney transplant testing services.
Three new studies focusing on the heart, lungs, and kidneys add to a growing body of evidence in support of donor-derived cell-free DNA as an organ health measure.
Thermo Fisher Scientific Deal Expands Possibilities for Exosome Dx Business, Bio-Techne CEO Says
Premium
The deal with Thermo Fisher is for the development of Bio-Techne's second test in its Exosome Diagnostics portfolio, a multigene assay for kidney transplant rejection.
Bio-Techne, Thermo Fisher Scientific to Further Develop, Commercialize Kidney Transplant Rejection Assay
The exosome-based, liquid biopsy assay discriminates between T-cell mediated rejection and antibody mediated rejection to help improve patient outcomes.